Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

PLX Protalix BioTherapeutics Inc

1,155

0,025 (2,21%)

Zuletzt aktualisiert: 17:55:16

Verzögert um 15 Minuten

Upcoming Earnings Release Paired With Price Target Raise Sends Stock Soaring

A New Jersey-based healthcare company turned heads on Tuesday following HC Wainwright & Co. maintaining a buy rating while raising its price target from $7 to $10/share. This...

To read the full story on AllPennyStocks.com, click here.

Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Protalix BioTherapeutics Charts.

Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Protalix BioTherapeutics Charts.

News Protalix BioTherapeutics Inc

Form ARS - Annual Report to Security Holders
Freitag 17 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 17 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 10 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 10 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dienstag 2 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 26 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Levicept Appoints Eliot Forster as CEO
Donnerstag 30 November 2023 (6 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 6 November 2023 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 6 November 2023 (7 Monate vor) • Edgar (US Regulatory)

Upcoming Earnings Release Paired With Price Target Raise Sends Stock Soaring
Dienstag 31 Oktober 2023 (7 Monate vor) • AllPennyStocks.com

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Oktober 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 3 Oktober 2023 (8 Monate vor) • Edgar (US Regulatory)

Weitere Protalix BioTherapeutics Inc News-Artikel

Global Technology Acquis...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen